KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Shares Issued (2016 - 2020)

Pfizer (PFE) has disclosed Shares Issued for 9 consecutive years, with $206.0 million as the latest value for Q3 2020.

  • On a quarterly basis, Shares Issued rose 274.55% to $206.0 million in Q3 2020 year-over-year; TTM through Sep 2020 was $455.0 million, a 1.73% decrease, with the full-year FY2020 number at $425.0 million, up 7.87% from a year prior.
  • Shares Issued was $206.0 million for Q3 2020 at Pfizer, up from $34.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $625.0 million in Q3 2018 to a low of $34.0 million in Q2 2020.
  • A 5-year average of $205.2 million and a median of $160.0 million in 2018 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: crashed 91.2% in 2019, then skyrocketed 274.55% in 2020.
  • Pfizer's Shares Issued stood at $73.0 million in 2016, then surged by 182.19% to $206.0 million in 2017, then dropped by 22.33% to $160.0 million in 2018, then crashed by 43.12% to $91.0 million in 2019, then soared by 126.37% to $206.0 million in 2020.
  • Per Business Quant, the three most recent readings for PFE's Shares Issued are $206.0 million (Q3 2020), $34.0 million (Q2 2020), and $124.0 million (Q1 2020).